A month to go for the conference presentation, SP will slowly rise in anticipation of results with some mixed days in between.
Surely this has to be the catalyst that heightens the use of PromarkerD testing within the medical profession.
There's always the possibility of some other news in the meantime.
More comments emerging in relation to the unknown ongoing effects of the COVID19 virus. This is PIQ's area of research, another relevant diagnostic need.
Wonder if anything else will be announced along with Janssen's study results. The study has been ongoing so there could be a hint of further developments. Interesting time.
Ann: Appendix 4C and Quarterly Report - March 2020, page-30
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.020(6.15%) |
Mkt cap ! $49.87M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 28.5¢ | $201.7K | 642.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3253 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 57411 | 2 |
View Market Depth
| Last trade - 16.10pm 25/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |